Matsumoto, Tomoya http://orcid.org/0000-0002-1570-2713
Nagashima, Masaru
Kagaya, Wataru
Kongere, James
Gitaka, Jesse
Kaneko, Akira
Funding for this research was provided by:
Japan Agency for Medical Research and Development (31-1338)
Japan Society for the Promotion of Science (21H05180)
Article History
Received: 31 October 2023
Accepted: 24 January 2024
First Online: 4 March 2024
Declarations
:
: This study is approved by the Mount Kenya University Independent Ethics and Research Committee (MKU-IERC) (approval number: MKU/ERC/2165) and the Ethics Committee at Otaru University of Commerce (approval number: OUC-2020–07-00).Written informed consent will be sought from study participants before the implementation of the financial incentive intervention, the baseline survey, and the follow-up survey. Participants have the right to withdraw from the study at any time and the option to withhold previously collected samples from any future analyses and studies.The samples collected in this study may potentially be used for other research purposes. This is clearly stated in the informed consent form. In such cases, we will obtain the necessary ethical approval and allow participants to opt out of this. All experiments will be carried out in adherence to WHO requirements and the Declaration of Helsinki.
: Not applicable—no identifying images or other personal or clinical details of participants are presented here or will be presented in reports of the trial results. The participant information materials and informed consent forms are available from the corresponding author on request.
: The authors declare that they have no competing interests.